Mrs. Margaret C. Maynard, M. ED., OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4930 Vermont Route 14, Sharon, VT 05065 Phone: 802-763-7276 |
News Archive
Researchers at the Hong Kong University of Science and Technology have found a way to stimulate the growth of axons, which may spell the dawn of a new beginning on chronic SCI treatments.
When tumor cells acquire the capacity to move around and invade other tissues, there is a risk of metastases and cancer treatment becomes more difficult. At the Institut Curie, CNRS Director of Research Philippe Chavrier and his group have just discovered how breast cancer cells break the bonds that tether them to the tumor. The basement membrane around the mammary gland is a barrier to the spread of cancer cells. Three proteins in the tumor cells transport enzymes needed to perforate this barrier, and another protein puts these enzymes in the right place.
Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).
WebMD Health Corp., the leading source of health information for consumers and health care professionals, is launching a new online resource to help Americans better understand the health care reform provisions that go into effect today. WebMD's health care reform resource presents a series of exclusive video interviews with Health and Human Services Secretary Kathleen Sebelius as well as in-depth editorial coverage, blogs, community and interactive polls.
For those with brain damage or neurological disorders - such as MS or Parkinson's - treatment could be as close as the wardrobe.
› Verified 4 days ago